Premium
Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast
Author(s) -
Madan Jyotsana R.,
Khobaragade Shweta,
Dua Kamal,
Awasthi Rajendra
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13370
Subject(s) - zeta potential , permeation , dispersity , ex vivo , pulmonary surfactant , particle size , chromatography , oleic acid , bioavailability , apremilast , nanocarriers , solid lipid nanoparticle , drug delivery , materials science , medicine , chemical engineering , pharmacology , nanotechnology , nanoparticle , chemistry , in vitro , psoriasis , biochemistry , membrane , dermatology , polymer chemistry , psoriatic arthritis , engineering
This work was aimed to formulate topical Apremilast (APM)‐loaded nanostructured lipid carriers (NLCs) for the management of psoriasis. NLCs were prepared by a cold homogenization technique using Compritol 888ATO, oleic acid, Tween 80 and Span 20, and Transcutol P as a solid lipid, liquid lipid, surfactant mixture, and penetration enhancer, respectively. Carbopol 940 was used to convert NLC dispersion into NLC‐based hydrogel to improve its viscosity for topical administration. The optimized formulation was characterized for size, polydispersity index (PDI), zeta potential (ZP), percentage of entrapment efficiency (%EE), and surface morphology. Furthermore, viscosity, spreadability, stability, in vitro drug diffusion, ex vivo skin permeation, and skin deposition studies were carried out. APM‐loaded NLCs showed a narrow PDI (0.339) with a particle size of 758 nm, a %EE of 85.5%, and a ZP of −33.3 mV. Scanning electron microscopy confirmed spherical shape of NLCs. in vitro drug diffusion and ex vivo skin permeation results showed low drug diffusion, sustained drug release, and 60.1% skin deposition. The present study confirms the potential of the nanostructured lipid form of poorly water‐soluble drugs for topical application and increased drug deposition in the skin.